Gene therapy preparations manufacturing · Pennsylvania
Iovance Cell Therapy Center (iCTC)
Philadelphia, PA · ~251 workers · 3 years of OSHA Injury Tracking Application data.
- A
- Excellent Safety Record
- 0.9
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
Iovance Cell Therapy Center (iCTC) runs at 26% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.
Iovance Cell Therapy Center (iCTC): 0.9 TCR = 26% of Gene therapy preparations manufacturing BLS 3.3 · 3y Form 300A (see methodology below)
Iovance Cell Therapy Center (iCTC) safety composite
Iovance Cell Therapy Center (iCTC) scores strongest on total case rate (tcr) (safer than 66% of same-industry peers) and weakest on dart rate (safer than 46%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
55/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- C 0.86 per 100 workers
Safer than 66% of industry peers
- DART rate
- D 0.6 per 100 workers
Safer than 46% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
Rising injury rate
Iovance Cell Therapy Center (iCTC): 0.6 → 1.2 TCR
Peak year 2024 @ 1.2 TCR · DART/TCR 0.7× in 2024
Iovance Cell Therapy Center (iCTC)'s TCR rose 0.6 from 0.6 in 2022 to 1.2 in 2024. In 2024, DART was 0.7× this establishment's average TCR (severity share of cases).
OSHA ITA Form 300A scorecard
Establishment book 325414 · Philadelphia, PA AT/BELOW-IND · MID
Grade A · TCR 0.9 · 26% of ind
- DART 0.6 DART
- RANK #6/13
- PHOTO Jackson ImmunoResearch
- BOOK 3y book
- INJ 7 inj
- SIZE ~251 FTE
Nearest TCR peer: Jackson ImmunoResearch (0.0 TCR gap)
Read with this employer → · Industry book → · Pennsylvania employers → · Look up another →
Iovance Cell Therapy Center (iCTC) in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
Iovance Cell Therapy Center (iCTC)
0.9 TCR
- Jackson Immuno
Jackson ImmunoResearch
0.9 TCR
- Bristol Myers
Bristol Myers Squibb Cell Therapy Operations
0.9 TCR
- Forge Biologic
Forge Biologics
0.9 TCR
- CRISPR Therape
CRISPR Therapeutics 33 New York Ave
0.8 TCR
What this shows Iovance Cell Therapy Center (iCTC) averages 0.9 TCR (26% of the Gene therapy preparations manufacturing BLS benchmark).
Iovance Cell Therapy Center (iCTC) TCR series: 2022=0.6 · 2023=0.8 · 2024=1.2 · BLS 3.3
Where Iovance Cell Therapy Center (iCTC) falls in its industry
234 Gene therapy preparations manu establishmentsSafer than 66% of graded establishments in this industry, whose median TCR is 1.2.
Narrower to Pennsylvania alone (the establishments it most directly competes with for workers and contracts): ranked #6 safest of 13 Gene therapy preparations manu employers in Pennsylvania.
Iovance Cell Therapy Center (iCTC) has more employees than the Gene therapy preparations manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 1.2 | 0.6 | 4 | 0 | 0 |
| 2023 | 0.8 | 0.8 | 2 | 0 | 0 |
| 2022 | 0.6 | 0.6 | 1 | 0 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
325414 · PA · Philadelphia
234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 22,692 rated employers in Pennsylvania with headcount on file · 1,431 employers in Philadelphia, PA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | Jackson ImmunoResearch | 0.9 TCR |
| NAICS-TCR | CRISPR Therapeutics 33 New York Ave | 0.8 TCR |
| NAICS-TCR | Bristol Myers Squibb Cell Therapy Operations | 0.9 TCR |
| NAICS-TCR | Forge Biologics | 0.9 TCR |
| STATE-SIZE | Range Resources Appalachia, LLC | 251 FTE |
| STATE-SIZE | Bruce Mansfield | 251 FTE |
| STATE-SIZE | Annex Building | 251 FTE |
| STATE-SIZE | Adhesives Research, Inc. | 251 FTE |
| CITY-NEAR | FIVE BELOW INC | 19,600 FTE |
| CITY-NEAR | Hospital of University of Pennsylvania | 13,423 FTE |
| CITY-NEAR | Children's Hospital of Philadelphia - Main Hospital | 9,638 FTE |
| CITY-NEAR | The Children's Hospital of Philadelphia - Main Campus | 9,129 FTE |
| NAT-TCR | Main - 002 | 0.9 TCR |
| NAT-TCR | Ceci Brothers Inc. | 0.9 TCR |
| NAT-TCR | StandardAero | 0.9 TCR |
| NAT-TCR | GRAD Knoxville | 0.9 TCR |
| NAT-SIZE | Alliance Care Rehabilitation & Nursing Center | 251 FTE |
| NAT-SIZE | LFB American Plasma-Greenacres | 251 FTE |
| NAT-SIZE | Douglasville Nursing and Rehabilitation Center, LLC | 251 FTE |
| NAT-SIZE | California Office | 251 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.